Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
- Status
- TERMINATED
- Phase
- NA
A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
- Status
- TERMINATED
- Phase
- N/A
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
- Status
- COMPLETED
- Phase
- N/A
Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and High-dose Melphalan at Myeloma Relapse
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone
- Status
- COMPLETED
- Phase
- PHASE3